Skip to content.

Searchlight Pharma acquires Miravo Healthcare for C$91.4M

Date Closed

March 14, 2023

Lead Office



91.40 Million CAD

On March 14, 2023, Searchlight Pharma Inc. ("Searchlight") closed on the previously announced plan of arrangement to acquire Miravo Healthcare ("Miravo") for C$91.4 million.  In connection with the Arrangement, Searchlight acquired 11,388,282 company shares, representing 100% of the issued and outstanding company shares, for cash consideration of $1.35 per company share.  The Company Shares will be de-listed from the TSX and the Company will apply to cease to be a reporting issuer in each of the provinces of Canada.

Searchlight, headquartered in Montreal, is a leading Canadian-based specialty healthcare company that executes best-in-class search, acquisition, commercialization, and focused development of innovative and unique specialty healthcare products.

Miravo is a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products.

McCarthy Tétrault advised Searchlight with a team led by Clemens Mayr that included Deandra Schubert, Victoria de Luna, Richard O’Doherty, Eve Tessier, Mathilde Melancon-Brais, Janie Lambert-Roy and Quentin Pérès (Business).